Plasma omentin-1 levels are related to exercise performance in obese women and increase upon aerobic endurance training

Experimental and Clinical Endocrinology and Diabetes

Volumn 123, Issue 3, 2015, Pages 187-192

  Wilms, B ^a,b   Ernst, B ^a,c   Gerig, R ^a,d   Schultes, B ^a,c,e  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c Kantonsspital St Gallen   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e Interdisciplinary Obesity Center eSwiss Medical and Surgical Center   (Switzerland)

Author keywords

adipokines; cardiopulmonary fitness; glucose metabolism; myokines

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; INSULIN; OMENTIN 1; UNCLASSIFIED DRUG; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADULT; AEROBIC EXERCISE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; ENDURANCE TRAINING; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID ANALYSIS; LUNG FUNCTION; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WHOLE BODY VIBRATION; BLOOD; ENDURANCE; KINESIOTHERAPY; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME;

ADULT; CYTOKINES; EXERCISE THERAPY; FEMALE; GPI-LINKED PROTEINS; HUMANS; LECTINS; MIDDLE AGED; OBESITY; PHYSICAL ENDURANCE; TREATMENT OUTCOME;

EID: 84925262432     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0034-1398504     Document Type: Article

References (27)

1. Schaffler A., Neumeier M., Herfarth H. et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochimica et biophysica acta: 2005; 1732 96 102 10.1016/j.bbaexp.2005.11.005
2. Yang R. Z., Lee M. J., Hu H. et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. American journal of physiology Endocrinology and metabolism: 2006; 290 E1253 E1261 10.1152/ajpendo.00572.2004
3. Barth S., Klein P., Horbach T. et al. Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: relation to endocrine and clinical parameters. Obesity facts: 2010; 3 245 251 10.1159/000319508
4. Rabe K., Lehrke M., Parhofer K. G. et al. Adipokines and insulin resistance. Molecular medicine: 2008; 14 741 751 10.2119/2008-00058.Rabe
5. de Souza Batista C. M., Yang R. Z., Lee M. J. et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes: 2007; 56 1655 1661 10.2337/db06-1506
6. Auguet T., Quintero Y., Riesco D. et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC medical genetics: 2011; 12 60 10.1186/1471-2350-12-60
7. Urbanova M., Dostalova I., Trachta P. et al. Serum concentrations and subcutaneous adipose tissue mRNA expression of omentin in morbid obesity and type 2 diabetes mellitus: the effect of very-low-calorie diet, physical activity and laparoscopic sleeve gastrectomy. Physiological research/Academia Scientiarum Bohemoslovaca: 2014; 63 207 218
8. Catli G., Anik A., Abaci A. et al. Low omentin-1 levels are related with clinical and metabolic parameters in obese children. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association: 2013; 121 595 600 10.1055/s-0033-1355338
9. Pan H. Y., Guo L., Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes research and clinical practice: 2010; 88 29 33 10.1016/j.diabres.2010.01.013
10. El-Mesallamy H. O., El-Derany M. O., Hamdy N. M. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabetic medicine: a journal of the British Diabetic Association: 2011; 28 1194 1200 10.1111/j.1464-5491.2011.03353.x
11. Yoo H. J., Hwang S. Y., Hong H. C. et al. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovascular diabetology: 2011; 10 103 10.1186/1475-2840-10-103
12. Shang F. J., Wang J. P., Liu X. T. et al. Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals: 2011; 16 657 662 10.3109/1354750X.2011.622789
13. Narumi T., Watanabe T., Kadowaki S. et al. Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure. Cardiovascular diabetology: 2014; 13 84 10.1186/1475-2840-13-84
14. Moreno-Navarrete J. M., Ortega F., Castro A. et al. Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity: 2011; 19 1552 1559 10.1038/oby.2010.351
15. Saremi A., Asghari M., Ghorbani A. Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. Journal of sports sciences: 2010; 28 993 998 10.1080/02640414.2010.484070
16. Wilms B., Frick J., Ernst B. et al. Whole body vibration added to endurance training in obese women - a pilot study. International journal of sports medicine: 2012; 33 740 743 10.1055/s-0032-1306284
17. Schultes B., Frick J., Ernst B. et al. The effect of 6-weeks of aerobic exercise training on serum fetuin-A levels in non-diabetic obese women. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association: 2010; 118 754 756 10.1055/s-0030-1253418
18. Matthews D. R., Hosker J. P., Rudenski A. S. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia: 1985; 28 412 419
19. Laboratories ATSCoPSfCPF ATS statement: guidelines for the six-minute walk test. American journal of respiratory and critical care medicine. 2002; 166 111 117 10.1164/ajrccm.166.1.at1102
20. Borg G. Perceived exertion as an indicator of somatic stress. Scandinavian journal of rehabilitation medicine: 1970; 2 92 98
21. Pedersen B. K., Febbraio M. A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature reviews Endocrinology: 2012; 8 457 465 10.1038/nrendo.2012.49
22. Pedersen L., Hojman P. Muscle-to-organ cross talk mediated by myokines. Adipocyte: 2012; 1 164 167 10.4161/adip.20344
23. Daskalopoulou S. S., Cooke A. B., Gomez Y. H. et al. Plasma irisin levels progressively increase in response to increasing exercise workloads in young, healthy, active subjects. European journal of endocrinology/European Federation of Endocrine Societies: 2014; 171 343 352 10.1530/EJE-14-0204
24. Huh J. Y., Mougios V., Skraparlis A. et al. Irisin in response to acute and chronic whole-body vibration exercise in humans. Metabolism: clinical and experimental: 2014; 63 918 921 10.1016/j.metabol.2014.04.001
25. Huh J. Y., Mougios V., Kabasakalis A. et al. Exercise-Induced Irisin Secretion Is Independent of Age or Fitness Level and Increased Irisin May Directly Modulate Muscle Metabolism Through AMPK Activation. The Journal of clinical endocrinology and metabolism: 2014; 99 E2154 E2161 10.1210/jc.2014-1437
26. Luque-Ramirez M., Martinez-Garcia M. A., Montes-Nieto R. et al. Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge. Human reproduction: 2013; 28 1908 1918 10.1093/humrep/det097
27. Hamnvik O. P., Thakkar B., Chamberland J. et al. Omentin-1 levels are reduced by pharmacologic doses of leptin, but remain unaffected by energy deprivation and display no day-night variation. International journal of obesity: 2014; 10.1038/ijo.2014.106